Stay updated on Pembrolizumab+Chemo vs Placebo+Chemo in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Chemo vs Placebo+Chemo in TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Chemo vs Placebo+Chemo in TNBC Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.5%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check80 days agoChange DetectedThe page has been updated to include new drug information related to Triple Negative Breast Cancer (TNBC), specifically mentioning Gemcitabine and Carboplatin, while significant details about the study's design and criteria have been removed.SummaryDifference21%
Stay in the know with updates to Pembrolizumab+Chemo vs Placebo+Chemo in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemo vs Placebo+Chemo in TNBC Clinical Trial page.